PIK3IP1 and cancer: In this regard, further elucidation of how PI3K activity is regulated by more subtle modulators of the pathway like PIK3IP1 and BCAP may lead to novel approaches to tune PI3K activity for enhancement or inhibition of lymphocyte responses to infection or cancer.